Order Stylage® S Bi-Soft for Clinics

Stylage® S Bi-Soft is a sterile hyaluronic acid dermal filler supplied in two 0.8 mL prefilled syringes for professional aesthetic use. Licensed clinics, med spas, and healthcare professionals can order Stylage S Bi-Soft for fine, superficial facial-line correction where controlled intradermal placement is required. The pack includes sterile needles, traceability labels, and an insert to support treatment-room setup and professional documentation.

This preparation is selected for delicate facial zones such as periorbital, perioral, and selected glabellar lines. It is intended for trained injectors who assess anatomy, injection depth, product volume, and aftercare according to their clinical protocol. Med Wholesale Supplies serves licensed professional accounts with brand-name medical products sourced through vetted distribution channels and supported by US distribution.

Stylage S Bi-Soft Price, Pack Size, and Clinic Ordering

Clinics evaluating the Stylage S Bi-Soft price should account for the full box configuration, not only the syringe volume. Each unit contains 2 prefilled 0.8 mL syringes, 4 sterile 30G 1/2 inch needles, 1 package insert, and traceability labels. This format helps practices plan inventory around superficial wrinkle appointments and record lot-level details in patient charts.

Sign in to view current wholesale cost and account-specific volume tiers. Contract pricing may suit practices that use Stylage products regularly across facial rejuvenation protocols. Because dermal filler selection affects technique, depth, and expected tissue behavior, purchasing decisions should align with the injector’s training and the clinic’s approved product formulary.

For brand-level browsing, clinics can review the full Stylage product range. Practices building a broader filler inventory may also use Stylage range and use comparisons to understand how different gel options fit distinct treatment objectives.

What Stylage® S Bi-Soft Is Used For

Stylage® S Bi-Soft is a cross-linked hyaluronic acid gel used by trained professionals for correction of superficial facial wrinkles and fine lines. Hyaluronic acid is a naturally occurring molecule that attracts water; in dermal fillers, it is formulated as a sterile gel to support localized contouring, hydration, and line refinement in the treated plane.

This product is suited to subtle work in thin or mobile areas where a light, precise gel is preferred. Common clinic applications include fine periorbital lines, perioral rhytids, and selected glabellar creases. The clinical objective is typically refinement rather than structural volumization, so assessment and placement depth matter more than simply adding volume.

The Bi-Soft syringe format supports controlled handling during injection. In practice, clinicians may use the supplied needles or a practitioner-selected cannula when appropriate for anatomy and technique. Product choice should be guided by skin thickness, line depth, movement pattern, previous filler history, and the injector’s complication-management training.

How the HA Gel Works in Superficial Lines

The Stylage S Bi-Soft dermal filler uses cross-linked hyaluronic acid to create a soft gel matrix for intradermal placement. Cross-linking helps the gel maintain structure after injection, while hyaluronic acid’s water-binding properties support localized hydration. The result is a product profile intended for fine-line correction rather than deep lifting.

In thin skin, overcorrection or placement at the wrong depth can create visible irregularities. That is why this filler is positioned for qualified injectors who can place small aliquots with finesse and adjust technique by facial region. The gel’s role is to integrate into the target tissue plane and soften etched lines while preserving a natural appearance.

Clinics that want more background on the molecule behind HA fillers can read hyaluronic acid in aesthetic medicine. For Stylage-specific clinical positioning, Stylage filler performance considerations may help teams discuss product selection during internal training.

Pack Components and Documentation

Each box is configured for immediate professional use after standard clinic intake, product inspection, and procedural preparation. The Stylage S Bi-Soft syringe format gives injectors a ready-to-use sterile presentation while the supplied accessories support consistent setup across treatment rooms.

Before use, staff should inspect the package, lot number, expiry date, syringe integrity, and labeling. Traceability labels should be applied according to the clinic’s charting process. Reference SKU: 89728.

Clinic Workflow and Handling

Stylage® S Bi-Soft fits practices that maintain separate product choices for fine lines, moderate wrinkles, and volumizing indications. Keeping a light HA filler available can help injectors avoid using a heavier gel in areas where flexibility and subtlety are important. Inventory planning should reflect appointment mix, injector preference, and the clinic’s established treatment protocols.

Storage and handling should follow the manufacturer’s package insert and the clinic’s medical inventory procedures. Keep the product sealed until preparation, maintain sterility, and do not use a syringe if the packaging is damaged or the gel appears compromised. Orders are supported with temperature-controlled handling when required and tracked US delivery.

Quick tip: Assign traceability-label placement to one staff role so lot documentation stays consistent across rooms.

Professional Applications and Treatment Planning

This filler is best understood as a precision product for superficial correction. In aesthetic planning, injectors may combine a light HA filler with neuromodulators, skin boosters, energy-based devices, or other filler types, depending on the treatment plan and patient assessment. The product should not be treated as interchangeable with deeper or more volumizing fillers solely because it belongs to the same brand family.

Typical decision points include skin thickness, wrinkle depth, prior treatments, inflammation risk, vascular anatomy, and the patient’s tolerance for staged correction. For perioral lines, clinicians may consider how muscle movement and lip support influence the final plan. For periorbital concerns, conservative placement and anatomical caution are especially important because the skin is thin and vascular structures are clinically significant.

Clinics comparing product families can use Stylage and Juvéderm distinctions for educational context. Practices focused on lip-area protocols may also find Stylage lip filler considerations useful when building a broader aesthetic menu.

With Lidocaine and Without Lidocaine Considerations

Clinics often evaluate whether to stock Stylage S Bi-Soft with lidocaine or a non-lidocaine presentation. This product record identifies the 2 x 0.8 mL Stylage® S Bi-Soft pack; consult the package insert for full composition and any anesthetic content before use. Do not assume anesthetic content from similar product names, regional packaging, or keyword phrasing.

If a lidocaine-containing option is preferred for a clinic protocol, review the separate Stylage S Bi-Soft with Lidocaine presentation. Selection should consider patient history, allergy screening, injector preference, comfort-management protocols, and the clinic’s documentation process.

When moving between lidocaine and non-lidocaine presentations, staff should verify the box name, insert, and syringe labeling before room setup. This prevents unintended product substitution and supports accurate charting.

Safety, Contraindications, and Professional Precautions

Dermal fillers require professional administration by qualified healthcare providers trained in facial anatomy, aseptic technique, and complication recognition. Expected transient injection-site reactions can include redness, tenderness, pain, itching, swelling, bruising, and small bumps. These effects are generally localized, but the clinician should provide aftercare instructions and escalation guidance according to their medical protocol.

Serious complications are uncommon but can occur with HA injectables, especially if product enters or compresses a blood vessel. Clinicians should be prepared to identify signs such as unusual pain, blanching, color change, visual symptoms, or tissue compromise and act according to established emergency protocols. Patient history, contraindication screening, anticoagulant use, skin infection, immune status, allergy history, and previous filler placement should be considered before treatment.

Aseptic technique is essential. Do not inject through inflamed, infected, or compromised skin. Use single-use components as directed, discard used needles safely, and avoid reusing syringes or accessories. Clinics should maintain policies for consent, lot documentation, adverse-event recording, and post-procedure follow-up.

Comparable Stylage Products

Stylage® S Bi-Soft is positioned for superficial line correction. Practices that need a different gel behavior may consider adjacent Stylage presentations based on treatment depth and protocol fit. Any switch should be approved by the clinical lead because gel choice affects injection plane, volume planning, and expected tissue response.

• Stylage M Bi-Soft: an adjacent Stylage option used when clinic protocols require a different HA filler profile.
• Stylage M Bi-Soft with Lido: a related presentation for practices that use lidocaine-containing fillers.
• Stylage L Bi-Soft: a larger-pack Stylage option for different treatment planning needs.

Comparable products should be evaluated by indication, depth, rheology, pack configuration, and injector experience. Similar branding does not make products clinically identical.

Availability, Substitutions, and Inventory Planning

Authentic Stylage S Bi-Soft supply supports consistent clinic protocols and patient recordkeeping. When planning reorder cadence, consider appointment volume, provider preference, seasonal demand, and expiration dating. Clinics using multiple Stylage presentations should store and label them so staff can distinguish S, M, L, lidocaine, and non-lidocaine boxes during room preparation.

If a substitution is considered, confirm it with the clinical team before changing technique or treatment plans. A substitute should be chosen for comparable clinical purpose, not only because it is part of the same brand family. Document any product change in the patient chart and ensure staff understand the revised injection approach.

Authoritative Sources

Laboratoires Vivacy official website

This content is for informational purposes only and is not a substitute for professional medical advice.